OUTCOMES OF PEOPLE LIVING WITH HIV IN TWO PUBLIC-SECTOR PSYCHIATRIC FACILITIES IN THE EASTERN CAPE USING EFAVIRENZ-CONTAINING REGIMENS
- PMID: 33884345
- PMCID: PMC8047287
- DOI: 10.21010/ajid.v14i2.2
OUTCOMES OF PEOPLE LIVING WITH HIV IN TWO PUBLIC-SECTOR PSYCHIATRIC FACILITIES IN THE EASTERN CAPE USING EFAVIRENZ-CONTAINING REGIMENS
Abstract
Background: People with mental disorders are more vulnerable to human immunodeficiency virus (HIV) infection. A part of first-line treatment for HIV, efavirenz, is routinely avoided in patients with mental illness due to the risk of potential aggravation of the mental illness. This study aimed to determine the outcomes of people living with HIV/AIDS who were mental healthcare users admitted to two public-sector psychiatric facilities and who were prescribed an efavirenz-containing regimen.
Materials and methods: A retrospective drug utilization study was conducted at two public-sector psychiatric hospitals in the Eastern Cape of South Africa. Patients aged 18 years or older living with HIV were included in the study. Follow-up reviews were conducted at four, 12 and 24 weeks. The patients were seen by doctors at the hospital and notes on progress and medication were recorded in medical records. The files were then reviewed.
Results: A total of 37 patients were enrolled. However, just 26 were reviewed at 24 weeks. A total of 43.2% (n=16) were female patients and the average age of the patients was 39.38±8.76 years. At the baseline, 32.4% (n=12) patients were diagnosed with schizophrenia. A total of 81.08% (n=30) of patients experienced an improvement in psychiatric symptoms after 24 weeks. Of these, 43.3% (n=13) were on an efavirenz-containing regimen.
Conclusion: Majority of the patients demonstrated an improvement in their psychiatric conditions to the extent that they were discharged into the community. This finding suggests that patients with psychiatric disorders on efavirenz can experience stabilisation of their psychiatric symptoms.
Keywords: HIV-positive; efavirenz-containing regimen; neuropsychiatric; outcomes; psychiatric.
Copyright: © 2020 Afr. J. Infect. Diseases.
Conflict of interest statement
Conflict of interest: The authors declare that they have no conflict of interest associated with this study.
Similar articles
-
Incidence of neuropsychiatric side effects of efavirenz in HIV-positive treatment-naïve patients in public-sector clinics in the Eastern Cape.South Afr J HIV Med. 2016 Jun 30;17(1):452. doi: 10.4102/sajhivmed.v17i1.452. eCollection 2016. South Afr J HIV Med. 2016. PMID: 29568611 Free PMC article.
-
Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records.Lancet Glob Health. 2020 Oct;8(10):e1326-e1334. doi: 10.1016/S2214-109X(20)30279-5. Lancet Glob Health. 2020. PMID: 32971055 Free PMC article.
-
Virologic Response Following a Switch to Dolutegravir-based Regimen in People Living with HIV/AIDS at a Tertiary Care Center in Nepal.Kathmandu Univ Med J (KUMJ). 2022 Oct-Dec;20(80):438-442. Kathmandu Univ Med J (KUMJ). 2022. PMID: 37795720
-
Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.Health Technol Assess. 2001;5(21):1-75. doi: 10.3310/hta5210. Health Technol Assess. 2001. PMID: 11532238 Review.
-
HIV and mental illness in Malawi and the neuropsychiatric sequelae of efavirenz.Malawi Med J. 2018 Mar;30(1):40-45. doi: 10.4314/mmj.v30i1.9. Malawi Med J. 2018. PMID: 29868159 Free PMC article. Review.
References
-
- Antoniou T, Lin-in A. Interactions between recreational drugs and antiretroviral agents. Annals of Pharmacotherapy. 2002;36:1598–1613. - PubMed
-
- Arendt G. Affective disorders in patients with HIV infection:Impact of antiretroviral therapy. CNS Drugs. 2006;20:507–518. - PubMed
-
- Badkoobehi H, Chana G, Everall I.P. Psychiatric aspects of HIV. Psychiatry. 2006;5:85–88.
-
- Bell J.E, Arango J, Anthony I.C. Neurobiology of multiple insults:HIV-1 associated brain disorders in those who use illicit drugs. Journal of Neuroimmune Pharmacology. 2006;1:182–191. - PubMed
-
- Burdo T.H, Katner S.N, Taffe M.A. Neuroimmunity, drugs of abuse and neuroAIDS. Journal of Neuroimmune Pharmacology. 2006;1:41–49. - PubMed
LinkOut - more resources
Full Text Sources